Source: Federation of American Societies for Experimental Biology
Date: January 28, 2010
Summary:
Using cells from mice, scientists discovered a new strategy for making embryonic stem cell transplants less likely to be rejected by a recipient's immune system. This strategy involves fusing bone marrow cells to embryonic stem cells. Once fused, hybrid cells have DNA from both donor and recipient, raising hopes that immune rejection of embryonic stem cell therapies can be avoided without drugs. This strategy, described in a new research report appearing in the February 2010 print issue of The FASEB Journal, involves fusing bone marrow cells to embryonic stem cells.
